Ganciclovir showed no clear difference in all‐cause death compared with aciclovir (moderate certainty).
Valaciclovir showed no clear difference in all‐cause death compared with ganciclovir or valganciclovir (low certainty).
Extended showed no clear difference in all‐cause death compared with short‐duration valganciclovir (low certainty).
Antiviral prophylaxis leads to lower all‐cause death compared with placebo or no treatment (high certainty).
Low showed no clear difference in all‐cause death compared with standard dose valganciclovir (low certainty).
Maribavir showed no clear difference in all‐cause death compared with ganciclovir (low certainty).
The review found no eligible studies for this question.
It is very uncertain whether the intervention changes all‐cause death (very low certainty).
It is very uncertain whether metformin changes all‐cause death ( compared with placebo (very low certainty).
Metformin showed no clear difference in all‐cause death ( compared with active control (low certainty).
Cerebrolysin or Cerebrolysin‐like agents showed no clear difference in all‐cause death ( compared with placebo (moderate certainty).
Long‐acting muscarinic antagonist (LAMA) plus long‐acting… probably leads to higher all‐cause death compared with LABA plus inhaled corticosteroid (ICS) (moderate certainty).
Warfarin showed no clear difference in all‐cause death compared with placebo or no treatment (low certainty).
Rivaroxaban showed no clear difference in all‐cause death compared with placebo (high certainty).
Rotarix showed no clear difference in all‐cause death compared with placebo (moderate certainty).
RotaTeq showed no clear difference in all‐cause death compared with placebo (low certainty).
Rotasiil showed no clear difference in all‐cause death compared with placebo (moderate certainty).
It is very uncertain whether rotavac changes all‐cause death compared with placebo (very low certainty).